Hims & Hers Health (HIMS) has emerged as a disruptive force in telehealth, leveraging technology and personalization to address highly-personal health conditions while achieving scalable profitability ...

Selma Blair discusses her health journey, updating fans on her Multiple Sclerosis, sharing her diagnosis story, and revealing ...

A nurse inspired to work at Spaulding Rehab after they treated her father will be running the Boston Marathon for them.

The alleged facts of this case — where a mother is accused of intentionally taking the life of her young child — are ...

A year before she passed away, actress Michelle Trachtenberg sought to let her supporters know she was in good health.

Taking a mental health leave from work is becoming more of an option for people in the United States even thought most of ...

The stock market fell sharply anew on Wednesday, with all major indices ending in the red, as investor sentiment was dampened ...

HIMS has experienced similar dramatic drops before. During the 2022 inflation surge, the stock fell 87%, and in 2020, it ...

Truist analyst Jailendra Singh lowered the firm’s price target on Hims & Hers to $33 from $39 and keeps a Hold rating on the shares as part ...

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 12.5% in the afternoon session after the company revealed it will offer Eli Lilly's weight-loss medications (Zepbound ...

It is hard to get excited after looking at Hims & Hers Health's (NYSE:HIMS) recent performance, when its stock has declined 34% over the past month. However, a closer look at its sound financials ...

Hims & Hers Health stock plummeted after an FDA decision that prevents the company from selling compounded semaglutide. The company still expects to deliver strong revenue growth, though ...